BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36298835)

  • 1. The Novel
    Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication.
    Luganini A; Sibille G; Pavan M; Mello Grand M; Sainas S; Boschi D; Lolli ML; Chiorino G; Gribaudo G
    Antiviral Res; 2023 Nov; 219():105734. PubMed ID: 37852322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Generation
    Calistri A; Luganini A; Mognetti B; Elder E; Sibille G; Conciatori V; Del Vecchio C; Sainas S; Boschi D; Montserrat N; Mirazimi A; Lolli ML; Gribaudo G; Parolin C
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
    Li J; Takeda M; Imahatakenaka M; Ikeda M
    J Med Virol; 2024 Jan; 96(1):e29372. PubMed ID: 38235544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
    Gehlot P; Vyas VK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
    Demarest JF; Kienle M; Boytz R; Ayres M; Kim EJ; Patten JJ; Chung D; Gandhi V; Davey RA; Sykes DB; Shohdy N; Pottage JC; Kumar VS
    Antiviral Res; 2022 Oct; 206():105403. PubMed ID: 36041646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the Antiviral Efficacy of RNA-Dependent RNA Polymerase Inhibition by Combination with Modulators of Pyrimidine Metabolism.
    Liu Q; Gupta A; Okesli-Armlovich A; Qiao W; Fischer CR; Smith M; Carette JE; Bassik MC; Khosla C
    Cell Chem Biol; 2020 Jun; 27(6):668-677.e9. PubMed ID: 32442424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
    Zhang L; Zhang J; Wang J; Ren C; Tang P; Ouyang L; Wang Y
    Eur J Med Chem; 2022 Mar; 232():114176. PubMed ID: 35151222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
    Smee DF; Hurst BL; Day CW
    Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.
    Yang CF; Gopula B; Liang JJ; Li JK; Chen SY; Lee YL; Chen CS; Lin YL
    Emerg Microbes Infect; 2018 Nov; 7(1):187. PubMed ID: 30459406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia.
    Gaidano V; Houshmand M; Vitale N; Carrà G; Morotti A; Tenace V; Rapelli S; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Cilloni D; Cignetti A; Saglio G; Circosta P
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33670894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-
    Sainas S; Giorgis M; Circosta P; Poli G; Alberti M; Passoni A; Gaidano V; Pippione AC; Vitale N; Bonanni D; Rolando B; Cignetti A; Ramondetti C; Lanno A; Ferraris DM; Canepa B; Buccinnà B; Piccinini M; Rizzi M; Saglio G; Al-Karadaghi S; Boschi D; Miggiano R; Tuccinardi T; Lolli ML
    J Med Chem; 2022 Oct; 65(19):12701-12724. PubMed ID: 36162075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
    Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold.
    Li C; Zhou Y; Xu J; Zhou X; Liu S; Huang Z; Qiu Z; Zeng T; Gou K; Tao L; Zhong X; Yang X; Zhou Y; Su N; Chen Q; Zhao Y; Luo Y
    Eur J Med Chem; 2022 Dec; 243():114737. PubMed ID: 36115209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide Suppresses Influenza A Virus Replication
    Soudani N; Hage-Sleiman R; Karam W; Dbaibo G; Zaraket H
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study.
    Galati S; Sainas S; Giorgis M; Boschi D; Lolli ML; Ortore G; Poli G; Tuccinardi T
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
    Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
    PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
    Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
    Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses.
    Zheng Y; Li S; Song K; Ye J; Li W; Zhong Y; Feng Z; Liang S; Cai Z; Xu K
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.